Tokyo-based Meiji Seika Pharma has received approval in Japan to produce the world’s first self-amplifying mRNA COVID-19 vaccine without safety data.
The world's first COVID-19 self-amplifying mRNA (sa-mRNA) vaccine has been authorized in Japan; however, the vaccine's maker has not released any safety or effectiveness information.
In a press statement on November 28, Tokyo-based Meiji Seika Pharma stated that it has acquired approval to begin producing and selling its Kostaive sa-mRNA...
